Aristopharma Ltd. has launched Wikijet 2.5 mg/0.5 ml & 5 mg/0.5 ml Pre-filled Syringe Injection, which is the preparation of Tirzepatide INN.

Wikijet is the preparation of Tirzepatide, a GIP receptor and GLP-1 receptor agonist. It is a 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding and prolongs the half-life. Tirzepatide selectively binds to and activates both the GIP and GLP-1 receptors, the targets for native GIP and GLP-1. Tirzepatide lowers fasting and postprandial glucose concentration, decreases food intake, and reduces body weight in patients with type 2 diabetes mellitus.